Current issue
Archive
Videos
Articles in press
About the journal
Supplements
Editorial board
Reviewers
Abstracting and indexing
Subscription
Contact
Instructions for authors
Publication charge
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
3/2024
vol. 126 abstract:
Review article
Changes in the organ of vision in neurofibromatosis type 1 in the developmental age
Mirosława Grałek
1
,
Katarzyna Piasecka
1
,
Katarzyna Wasyliszyn-Sieroszewska
1
,
Anna Niwald
1
KLINIKA OCZNA 2024, 126, 3: 119-123
Online publish date: 2024/10/09
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Neurofibromatosis type 1 is a genetic disorder with clinical manifestations determined by their origin in the three germ layers. Globally, the prevalence of neurofibromatosis type 1 is estimated at 1 : 3,000 to 1 : 3,500. Clinical manifestations include both systemic and vision-related changes. Systemic disorders in affected children include primarily neurofibromatas manifesting as hamartoma, located in the skin, in various internal organs, and in the organ of vision. Ocular manifestations mainly present as eyelid abnormalities due to hamartomas, Lisch nodules on the iris, optic glioma, and glaucoma.
Diagnostics relies on clinical and imaging evaluations, as well as genetic testing. There is no causal treatment. The therapeutic management depends on each patient’s specific needs. Children with neurofibromatosis type 1 with ocular lesions require regular ophthalmic care. keywords:
neurofibromatosis type 1, etiology, general symptoms, ocular changes, management |
|